❌Con: Canlimitinnovation (ifmonopolized)“CaseStudyMentioned”Pro:Encouragesefficiency“Innovation”🌎ID&E:RegulatoryoversightprotectsfairnessTAVR-ARdeviceCon:ReducescompetitionHeartWareCon:Potential jobloss insmaller firmsCon:AntitrustchallengesPro:ImprovespatientoutcomesPro:Createscompetitiveadvantage✅Pro:Lowerslong-termcosts✅Pro:Encouragesefficiency🌎ID&E:Risk of biasintechnologyadoption✅Pro:Expandstreatmentoptions“Antitrust”ID&E: CouldcreateglobaldisparitiesCon:Raisescost forconsumers“Innovation”ID&E: Riskof bias intechnologyadoption❌Con:Raisescost forconsumers✅Pro:Drivesinnovation❌Con:Risk ofmarketmonopolyPro:Lowerslong-termcosts🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Could createglobaldisparitiesID&E: Mayreduceequitableaccess ifcosts rise❌Con:Reducescompetition✅Pro:Improvespatientoutcomes❌Con:Potential jobloss insmaller firmsThoratecEdwardsLifesciencesJenaValve✅Pro:PromotesfasterdevelopmentID&E:ImpactsaffordabilityforunderservedpopulationsID&E:Opportunityto designfor inclusionID&E:Regulatoryoversightprotectsfairness❌Con:StiflessmallercompetitorsCon: Stiflessmallercompetitors🌎ID&E:Opportunityto designfor inclusionPro:Drivesinnovation🌎ID&E:May reduceequitableaccess ifcosts rise❌Con:AntitrustchallengesCon: Riskof marketmonopoly🌎ID&E:Increasesaccess tolife-savingdevices“CaseStudyMentioned”“Antitrust”Con: Canlimitinnovation (ifmonopolized)Pro:Promotesfasterdevelopment✅Pro:CreatescompetitiveadvantagePro:ExpandstreatmentoptionsID&E:Increasesaccess tolife-savingdevices❌Con: Canlimitinnovation (ifmonopolized)“CaseStudyMentioned”Pro:Encouragesefficiency“Innovation”🌎ID&E:RegulatoryoversightprotectsfairnessTAVR-ARdeviceCon:ReducescompetitionHeartWareCon:Potential jobloss insmaller firmsCon:AntitrustchallengesPro:ImprovespatientoutcomesPro:Createscompetitiveadvantage✅Pro:Lowerslong-termcosts✅Pro:Encouragesefficiency🌎ID&E:Risk of biasintechnologyadoption✅Pro:Expandstreatmentoptions“Antitrust”ID&E: CouldcreateglobaldisparitiesCon:Raisescost forconsumers“Innovation”ID&E: Riskof bias intechnologyadoption❌Con:Raisescost forconsumers✅Pro:Drivesinnovation❌Con:Risk ofmarketmonopolyPro:Lowerslong-termcosts🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Could createglobaldisparitiesID&E: Mayreduceequitableaccess ifcosts rise❌Con:Reducescompetition✅Pro:Improvespatientoutcomes❌Con:Potential jobloss insmaller firmsThoratecEdwardsLifesciencesJenaValve✅Pro:PromotesfasterdevelopmentID&E:ImpactsaffordabilityforunderservedpopulationsID&E:Opportunityto designfor inclusionID&E:Regulatoryoversightprotectsfairness❌Con:StiflessmallercompetitorsCon: Stiflessmallercompetitors🌎ID&E:Opportunityto designfor inclusionPro:Drivesinnovation🌎ID&E:May reduceequitableaccess ifcosts rise❌Con:AntitrustchallengesCon: Riskof marketmonopoly🌎ID&E:Increasesaccess tolife-savingdevices“CaseStudyMentioned”“Antitrust”Con: Canlimitinnovation (ifmonopolized)Pro:Promotesfasterdevelopment✅Pro:CreatescompetitiveadvantagePro:ExpandstreatmentoptionsID&E:Increasesaccess tolife-savingdevices

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. ❌Con: Can limit innovation (if monopolized)
  2. “Case Study Mentioned”
  3. Pro: Encourages efficiency
  4. “Innovation”
  5. 🌎ID&E: Regulatory oversight protects fairness
  6. TAVR-AR device
  7. Con: Reduces competition
  8. HeartWare
  9. Con: Potential job loss in smaller firms
  10. Con: Antitrust challenges
  11. Pro: Improves patient outcomes
  12. Pro: Creates competitive advantage
  13. ✅Pro: Lowers long-term costs
  14. ✅Pro: Encourages efficiency
  15. 🌎ID&E: Risk of bias in technology adoption
  16. ✅Pro: Expands treatment options
  17. “Antitrust”
  18. ID&E: Could create global disparities
  19. Con: Raises cost for consumers
  20. “Innovation”
  21. ID&E: Risk of bias in technology adoption
  22. ❌Con: Raises cost for consumers
  23. ✅Pro: Drives innovation
  24. ❌Con: Risk of market monopoly
  25. Pro: Lowers long-term costs
  26. 🌎ID&E:Impacts affordability for underserved populations
  27. 🌎ID&E: Could create global disparities
  28. ID&E: May reduce equitable access if costs rise
  29. ❌Con: Reduces competition
  30. ✅Pro: Improves patient outcomes
  31. ❌Con: Potential job loss in smaller firms
  32. Thoratec
  33. Edwards Lifesciences
  34. JenaValve
  35. ✅Pro: Promotes faster development
  36. ID&E:Impacts affordability for underserved populations
  37. ID&E: Opportunity to design for inclusion
  38. ID&E: Regulatory oversight protects fairness
  39. ❌Con: Stifles smaller competitors
  40. Con: Stifles smaller competitors
  41. 🌎ID&E: Opportunity to design for inclusion
  42. Pro: Drives innovation
  43. 🌎ID&E: May reduce equitable access if costs rise
  44. ❌Con: Antitrust challenges
  45. Con: Risk of market monopoly
  46. 🌎ID&E: Increases access to life-saving devices
  47. “Case Study Mentioned”
  48. “Antitrust”
  49. Con: Can limit innovation (if monopolized)
  50. Pro: Promotes faster development
  51. ✅Pro: Creates competitive advantage
  52. Pro: Expands treatment options
  53. ID&E: Increases access to life-saving devices